0001415889-23-004865.txt : 20230314
0001415889-23-004865.hdr.sgml : 20230314
20230314184602
ACCESSION NUMBER: 0001415889-23-004865
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230313
FILED AS OF DATE: 20230314
DATE AS OF CHANGE: 20230314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gelder Mark S. MD
CENTRAL INDEX KEY: 0001564390
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36020
FILM NUMBER: 23732605
MAIL ADDRESS:
STREET 1: C/O A.P. PHARMA, INC.
STREET 2: 123 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Onconova Therapeutics, Inc.
CENTRAL INDEX KEY: 0001130598
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
BUSINESS PHONE: 267-759-3681
MAIL ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20090526
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC
DATE OF NAME CHANGE: 20001226
4
1
form4-03142023_100352.xml
X0306
4
2023-03-13
0001130598
Onconova Therapeutics, Inc.
ONTX
0001564390
Gelder Mark S. MD
C/O ONCONOVA THERAPEUTICS, INC
12 PENNS TRAIL
NEWTOWN
PA
18940
false
true
false
false
CHIEF MEDICAL OFFICER
Stock Option (right to purchase)
0.73
2023-03-13
4
A
0
62000
0
A
2033-03-13
Common Stock
62000
62000
D
Restricted Stock Units
2023-03-13
4
A
0
20667
0
A
Common Stock
20667
20667
D
These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.
Each restricted stock unit is convertible into one share of common stock.
These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary
/s/ Mark Guerin, Attorney-in-Fact
2023-03-14